Chemical Structure (Fenoglide Figure 1)
Fenoglide
Product Images NDC 52725-490
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenoglide (NDC 52725-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Shore Therapeutics, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (90 Tablet Bottle Label)
Fenoglide is a medication available in tablet form with a strength of 40 mg. The usual dose information is not available and should be obtained from the package insert. The medication should be kept out of children's reach and dispensed in a USP tight container. It should be stored at 25°C with permitted excursions ranging from 15°-30°C. The medication is distributed by Shore Therapeutics, based in Stamford, CT. The NDC number for the medication is 52725-490-90, and it is available as a prescription-only medication.*
Principal Display Panel (90 Tablet Bottle Label)
This is a description of the usual dose, storage instructions, and distribution information for Fenoglide tablets, containing 120 mg of fenofibrate. The package insert contains prescribing information. The tablets should be kept in a USP tight container and stored at 25°C (77°F), with excursions permitted to 15°-30°C (50°-86°F). The drug is distributed by Shore Therapeutics, Inc. in Stamford, CT and includes an NDC number and lot/expiration information. It is a prescription drug and should be kept out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
